{"id":1067981,"date":"2021-11-07T01:41:15","date_gmt":"2021-11-07T05:41:15","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/mynz-closes-its-first-day-of-trading-on-the-nasdaq-capital-market\/"},"modified":"2024-08-18T11:41:35","modified_gmt":"2024-08-18T15:41:35","slug":"mynz-closes-its-first-day-of-trading-on-the-nasdaq-capital-market","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/mynz-closes-its-first-day-of-trading-on-the-nasdaq-capital-market.php","title":{"rendered":"MYNZ Closes Its First Day of Trading on the Nasdaq Capital Market"},"content":{"rendered":"<p><![CDATA[BERKELEY, Calif. and MAINZ, Germany, Nov.  05, 2021  (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (\u201cMainz Biomed\u201d or the \u201cCompany\u201d), a molecular genetics diagnostics company specializing in the early detection of cancer, today announced that its common stock commenced trading on the Nasdaq Capital Market today under the ticker symbol MYNZ. The shares closed above\u00a0the offering price at $9.99.]]><\/p>\n<p>Read the original here:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener\" href=\"https:\/\/www.globenewswire.com\/news-release\/2021\/11\/05\/2328766\/0\/en\/MYNZ-Closes-Its-First-Day-of-Trading-on-the-Nasdaq-Capital-Market.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"MYNZ Closes Its First Day of Trading on the Nasdaq Capital Market\">MYNZ Closes Its First Day of Trading on the Nasdaq Capital Market<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Read the original here: MYNZ Closes Its First Day of Trading on the Nasdaq Capital Market <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/mynz-closes-its-first-day-of-trading-on-the-nasdaq-capital-market.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":64,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-1067981","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1067981"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/64"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=1067981"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1067981\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=1067981"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=1067981"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=1067981"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}